Decision 1975/320 - 75/320/EEC: Council Decision of 20 May 1975 setting up a pharmaceutical committee

Please note

This page contains a limited version of this dossier in the EU Monitor.

1.

Current status

This decision has been published on June  9, 1975 and entered into force on May 20, 1975.

2.

Key information

official title

75/320/EEC: Council Decision of 20 May 1975 setting up a pharmaceutical committee
 
Legal instrument Decision
Number legal act Decision 1975/320
CELEX number i 31975D0320

3.

Key dates

Document 20-05-1975
Publication in Official Journal 09-06-1975; Special edition in Slovak: Chapter 01 Volume 001,Special edition in Estonian: Chapter 01 Volume 001,Special edition in Czech: Chapter 01 Volume 001,Special edition in Lithuanian: Chapter 01 Volume 001,Special edition in Slovenian: Chapter 01 Volume 001,OJ L 147, 9.6.1975,Special edition in Hungarian: Chapter 01 Volume 001,Special edition in Croatian: Chapter 01 Volume 002,Special edition in Portuguese: Chapter 13 Volume 004,Special edition in Swedish: Chapter 13 Volume 004,Special edition in Bulgarian: Chapter 01 Volume 001,Special edition in Romanian: Chapter 01 Volume 001,Special edition in Maltese: Chapter 01 Volume 001,Special edition in Spanish: Chapter 13 Volume 004,Special edition in Finnish: Chapter 13 Volume 004,Special edition in Latvian: Chapter 01 Volume 001,Special edition in Polish: Chapter 01 Volume 001
Effect 20-05-1975; Entry into force Date of document
End of validity 31-12-9999

4.

Legislative text

9.6.1975   

EN

Official Journal of the European Communities

L 147/23

 

COUNCIL DECISION

of 20 May 1975

setting up a pharmaceutical committee

(75/320/EEC)

THE COUNCIL OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Economic Community;

Having regard to the proposal from the Commission;

Whereas the implementation of the measures adopted by the Council as regards the approximation of the laws relating to proprietary medicinal products for human use may raise problems which should be jointly examined;

Whereas, to this end, a Committee should be set up, chaired by a representative of the Commission and composed of representatives of the Member States from those States' administrations,

HAS DECIDED AS FOLLOWS:

Article 1

A Committee called the ‘Pharmaceutical Committee’ shall be set up and attached to the Commission.

Article 2

Without prejudice to the tasks of the Committee for Proprietary Medicinal Products referred to in Article 8 of the Second Council Directive 75/319/EEC (1) of 20 May 1975 on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products, the task of this Committee shall be to examine:

 

any question relating to the application of Directives on proprietary medicinal products which are brought up by its Chairman — either on his initiative or at the request of the representative of a Member State;

 

any other question in the field of proprietary medicinal products brought up by its Chairman — either on his initiative or at the request of the representative of a Member State.

The Commission shall consult the Committee when preparing proposals for Directives in the field of proprietary medicinal products, and in particular when it considers any amendments to Council Directive 65/65/EEC (2) of 26 January 1965 on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products which it might have occasion to propose.

Article 3

  • 1. 
    The Committee shall consist of senior experts in public health matters from the Member States' administrations and each Member State shall have one representative.
  • 2. 
    There shall be one deputy for each representative. This deputy shall be entitled to participate in meetings of the Committee.
  • 3. 
    A representative of the Commission shall chair the Committee.

Article 4

The Committee shall adopt its rules of procedure.

Done at Brussels, 20 May 1975.

For the Council

The President

  • R. 
    RYAN
 

  • (1) 
    See page 13 of this Official Journal.
 


More

This text has been adopted from EUR-Lex.

 

5.

Sources and disclaimer

For further information you may want to consult the following sources that have been used to compile this dossier:

This dossier is compiled each night drawing from aforementioned sources through automated processes. We have invested a great deal in optimising the programming underlying these processes. However, we cannot guarantee the sources we draw our information from nor the resulting dossier are without fault.

 

6.

Full version

This page is also available in a full version containing the summary of legislation, the legal context, de Europese rechtsgrond, other dossiers related to the dossier at hand and finally the related cases of the European Court of Justice.

The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.

7.

EU Monitor

The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.